Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

REMUS PHARMA Fact Sheet  (REMA)



For a Limited Time: Get 3 Years of Access at the Price of 1


Here is the latest financial fact sheet of REMUS PHARMA. For more details, see the REMUS PHARMA quarterly results and REMUS PHARMA share price.

REMUS PHARMA Price History

Price Rs 7,456.2
Mkt Cap Rs m 10,983
Vol '000 0.8
P/E X  
P/CF X 122.3
EPS (TTM) Rs 0.0
1 Day % 3.5
No. of shares m 1.47
1 Week % -3.8
1 Month % 24.1
1 Year % -
52 week H/L Rs 8,747.0/1,711.3
As on May 10, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

REMUS PHARMA Financials

No. of Mths
Year Ending
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
REMUS PHARMA EQUITY SHARE DATA
High RsNANANANA 
Low RsNANANANA 
Sales per share (Unadj.) Rs11,919.018,418.0246.9413.1 
Earnings per share (Unadj.) Rs812.01,026.034.378.0 
Diluted earnings per shareRs5.57.023.357.7 
Cash flow per share (Unadj.) Rs918.01,201.035.982.4 
Dividends per share (Unadj.) Rs0002.00 
Adj. dividends per shareRs0.000.000.001.48 
Avg Dividend yield %0000 
Book value per share (Unadj.) Rs2,020.03,046.065.8175.6 
Adj. book value per shareRs13.720.744.7129.9 
Shares outstanding (eoy) m0.010.011.001.09 
Bonus / Rights / Conversions  0000 
Price / Sales ratio x0000 
Avg P/E ratio x0000 
P/CF ratio (eoy) x0000 
Price / Book Value ratio x0000 
Dividend payout %0002.6 
Avg Mkt Cap Rs m0000 
No. of employees `000NANANANA 
Total wages/salary Rs m29303455 
Avg. sales/employee Rs Th0000 
Avg. wages/employee Rs Th0000 
Avg. net profit/employee Rs Th0000 
REMUS PHARMA INCOME DATA
Net Sales Rs m119184247450 
Other income Rs m98716 
Total revenues Rs m128192254466 
Gross profit Rs m4841105 
Depreciation Rs m1225 
Interest Rs m0012 
Profit before tax Rs m111446114 
Minority Interest Rs m0000 
Prior Period Items Rs m0000 
Extraordinary Inc (Exp) Rs m0000 
Tax Rs m331229 
Profit after tax Rs m8103485 
Gross profit margin %3.34.116.723.4 
Effective tax rate %25.824.525.625.5 
Net profit margin %6.85.613.918.9 
REMUS PHARMA BALANCE SHEET DATA
Current assets Rs m487577113 
Current liabilities Rs m29779282 
Net working cap to sales %15.4-1.0-6.07.1 
Current ratio x1.61.00.81.4 
Inventory Days Days061116167 
Debtors Days Days498714431393 
Net fixed assets Rs m53581232 
Share capital Rs m001011 
"Free" reserves Rs m203056181 
Net worth Rs m203066191 
Long term debt Rs m32171 
Total assets Rs m53110158345 
Interest coverage x26.439.854.050.0 
Debt to equity ratio x0.10.100.4 
Sales to assets ratio x2.31.71.61.3 
Return on assets %16.29.722.325.3 
Return on equity %40.233.752.244.4 
Return on capital %49.443.070.444.4 
Exports to sales %0000 
Imports to sales %002.01.1 
Exports (fob) Rs m0000 
Imports (cif) Rs m0055 
Fx inflow Rs m119153232440 
Fx outflow Rs m321118 
Net fx Rs m116151220422 
REMUS PHARMA CASH FLOW
From Operations Rs m 13 28 50 53 
From Investments Rs m -6 -31 -45 -152 
From Financial Activity Rs m 1 -1 -2 118 
Net Cashflow Rs m 8 -4 3 19 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 70.6%
Institution 3.9%
Non-Institution 25.5%
Total 100.0%
Free Float 29.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off 1101 To 1103 South Tower, One 42 B/h Ashok Vatika Nr. Jayantilal Park, Brts Ambli Bopal Road, Ahmedabad - 380054
E-mail cs@remuspharma.com Web www.remuspharma.com
Tel 079-29999857 Fax
Sector TRADING Group Private sector
Tr Agent Link Intime India Pvt Ltd., 5th Floor 506 to 508 Amarnath Business Centre-1(Abc-1), Beside Gala Business Center, Nr. St. Xavier’s College Corner Off C G Road Ellis Bridge
CHM: Swapnil Jatinbhai Shah COMP SEC: Deval Bakulkumar Patel YEAR OF INC: 2015 NSE CODE: 788377 FV (Rs): 10 DIV YIELD (%): 0.0

Read: REMUS PHARMA 2022-23 Annual Report Analysis

More Trading Company Fact Sheets:   SUPREME PETR    BHANSALI ENG    MANALI PETRO    TAMILNADU PETROPRODUCTS    VIKAS LIFECARE    

Compare REMUS PHARMA With:   SUPREME PETR    BHANSALI ENG    MANALI PETRO    TAMILNADU PETROPRODUCTS    VIKAS LIFECARE    




Today's Market

Sensex Today Ends Higher | Nifty Tops 22,050 | Hindustan Zinc Up 16% on 500% Dividend Announcement Sensex Today Ends Higher | Nifty Tops 22,050 | Hindustan Zinc Up 16% on 500% Dividend Announcement(Closing)

On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.